A Migration-Focused Adaptation of EMDR for Psychological Distress Among Turkish Migrants
EMDR
2 other identifiers
interventional
38
2 countries
2
Brief Summary
Many people who migrate to new countries experience significant emotional and psychological challenges. These challenges can include depression, anxiety, stress, and difficulty adjusting to a new culture and society. This pilot study examined whether a specialized form of psychotherapy called Eye Movement Desensitization and Reprocessing (EMDR), adapted specifically for migration-related experiences, may help reduce these psychological difficulties and support social adaptation. Participants were first-generation Turkish adults living in five European countries-the Netherlands, the United Kingdom, France, Sweden, and Austria-who reported emotional distress associated with migration and adaptation challenges. They received 12 weekly individual sessions delivered by licensed EMDR therapists, focusing on distressing experiences and difficulties related to adjusting to life in a new country. Before and after the therapy, participants completed questionnaires measuring their levels of depression, anxiety, and stress, and their sense of social adaptation in their new communities. This is a small single-arm pilot study without a control group. It was designed to provide preliminary information that may inform larger controlled trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Oct 2025
Shorter than P25 for not_applicable depression
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 23, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 23, 2026
CompletedFirst Submitted
Initial submission to the registry
September 3, 2026
CompletedFirst Posted
Study publicly available on registry
September 16, 2026
CompletedSeptember 16, 2026
September 1, 2026
9 months
September 3, 2026
September 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depression Anxiety Stress Scales-21 (DASS-21)
Psychological distress was assessed using the DASS-21, the short form of the original 42-item DASS developed by Lovibond and Lovibond (1995). The Turkish adaptation of the DASS-21 was conducted by Yılmaz et al. (2017). The measure comprises three seven-item subscales assessing symptoms of depression, anxiety, and stress during the preceding week. Items are rated on a four-point Likert-type scale ranging from 0 (Did not apply to me at all) to 3 (Applied to me very much). The DASS-21 contains no reverse-scored items. Each subscale yields a score ranging from 0 to 21, and the total DASS-21 score ranges from 0 to 63. The Turkish version has demonstrated adequate internal consistency, with Cronbach's alpha coefficients of .82 for depression, .81 for anxiety, and .76 for stress (Yılmaz et al., 2017). In the present study, depression, anxiety, and stress were specified as the primary psychological outcomes.
Baseline (Before the first EMDR session) and post-treatment (Week 12, after final EMDR session)
Secondary Outcomes (1)
Social Cohesion Scale for Immigrants (SCSI)
Baseline (Before the first EMDR session) and post-treatment (Week 12, after final EMDR session)
Study Arms (1)
EMDR therapy
EXPERIMENTAL12 individual weekly online psychotherapy sessions delivered by licensed EMDR therapists. Each session is 45 minutes. Clinical focus of the intervention addresses migration-related psychological distress.
Interventions
Eye Movement Desensitization and Reprocessing (EMDR) based on the Adaptive Information Processing (AIP) model. EMDR employs bilateral stimulation to facilitate processing of distressing memories and maladaptive cognitions. This intervention addresses migration-related psychological distress. Sessions followed standard EMDR phases including history-taking, preparation, assessment, desensitization, installation, body scan, closure, and re-evaluation. No medication or control condition.
Eligibility Criteria
You may qualify if:
- First-generation Turkish adults who are currently residing outside Türkiye
- Currently residing outside Türkiye for a minimum of 6 months
- Reporting emotional distress or psychological difficulties related to migration and adaptation to a new country
- Literate and capable of providing informed consent
You may not qualify if:
- Current severe psychiatric condition (psychotic disorders, bipolar disorder, severe depression, or clinically significant suicide risk)
- Intellectual disability or cognitive impairment that would prevent informed consent or participation
- Concurrent intensive psychotherapy (more than one individual psychotherapy session per week), or active psychiatric treatment involving medication changes
- History of alcohol or substance dependence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Derin Kubilaylead
Study Sites (2)
Remote (online delivery via Zoom)
Utrecht, Netherlands
Remote (online delivery via Zoom)
Sivas, Turkey (Türkiye)
Related Publications (2)
de Jongh A, de Roos C, El-Leithy S. State of the science: Eye movement desensitization and reprocessing (EMDR) therapy. J Trauma Stress. 2024 Apr;37(2):205-216. doi: 10.1002/jts.23012. Epub 2024 Jan 28.
PMID: 38282286BACKGROUNDKorn DL, Leeds AM. Preliminary evidence of efficacy for EMDR resource development and installation in the stabilization phase of treatment of complex posttraumatic stress disorder. J Clin Psychol. 2002 Dec;58(12):1465-87. doi: 10.1002/jclp.10099.
PMID: 12455016BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Derin Kubilay, MA
Utrecht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 3, 2026
First Posted
September 16, 2026
Study Start
October 23, 2025
Primary Completion
July 23, 2026
Study Completion
July 23, 2026
Last Updated
September 16, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are not publicly available. The data were collected within a psychotherapeutic treatment context, and participants were assured that all information provided would remain confidential; consent for sharing data with third parties was not obtained. The small sample size (N = 16) and the distribution of participants across five countries further limit the possibility of meaningful de-identification. Requests for access will be considered on a case-by-case basis by the corresponding author and would require prior approval from the institutional ethics committee.